Comprehensive evaluation of older patients with suspected malignancy: 5-year experience of a tertiary geriatric inpatient unit [0.03%]
疑似恶性肿瘤老年人的综合评估：三级老年病病房5年经验总结
Bahar Bektan Kanat,Veysel Suzan,Gulru Ulugerger Avci et al.
Bahar Bektan Kanat et al.
Objective: Geriatric cancer population is growing. Both cancer and geriatric conditions are associated with some degree of inflammatory burden. To comprehensively present our five years of experience in patients with susp...
Understanding US healthcare provider preferences for consumption of publication content: opportunities to leverage omnichannel approaches [0.03%]
了解美国医疗提供者对内容消费的偏好：利用全渠道方法的机会
Jessica B Bessler,William Fazzone,Nancy Sladicka et al.
Jessica B Bessler et al.
Objective: Understanding the healthcare provider (HCP) journey of discovering and consuming medical and scientific information is critical for optimizing publication reach. A survey was conducted in 2019-2020 to understan...
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance [0.03%]
接受难治性抑郁障碍治疗的患者使用艾斯 ketamine鼻喷雾剂的情况及真实世界用药模式（私企或公共保险）
Amanda Teeple,Maryia Zhdanava,Dominic Pilon et al.
Amanda Teeple et al.
Objective: To describe access and real-world use patterns of esketamine nasal spray among adults with treatment-resistant depression (TRD) with private or public insurance. ...
Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims [0.03%]
美国HIV感染人群从非核苷逆转录酶抑制剂或蛋白酶抑制剂转换为整合酶抑制剂后的体重增加：电子病历和处方登记分析
Jenny Tse,Girish Prajapati,Xiaohui Zhao et al.
Jenny Tse et al.
Objectives: Real-world data evaluating weight changes in people living with HIV (PLWH) following switch to integrase strand transfer inhibitor (INSTI), specifically bictegravir (BIC), are limited. This retrospective cohor...
The prognostic effect of the systemic immune-inflammation index on overall survival of periampullary cancer [0.03%]
系统免疫炎症指数对壶腹周围癌患者总生存期的预后价值评估
Mesut Yur,Şafak Özer Balin,Erhan Aygen et al.
Mesut Yur et al.
Objective: The systemic immune-inflammation index (SII) is used to assess survival in many cancers. SII has been examined separately in pancreatic head, ampulla, and distal choledochus cancers, and different cut-off value...
Relationship between complications of type 2 diabetes and thyroid nodules [0.03%]
2 型糖尿病并发症与甲状腺结节的关系
Xuexue Zhang,Xujie Wang,Jian Liu et al.
Xuexue Zhang et al.
Objective: Recent evidence suggests that diabetes is a risk factor for thyroid nodules. However, the relationship between complications of type 2 diabetes and the risk of thyroid nodules remains unclear. This present stud...
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay [0.03%]
精神分裂症住院期间新使用第二代口服或长效注射抗精神病药的连续性治疗
Charmi Patel,Dominic Pilon,Laura Morrison et al.
Charmi Patel et al.
Background: Maintaining continuity of care after schizophrenia-related hospitalization is challenging for patients and healthcare providers and systems. Prior evidence suggests that second-generation long-acting injectabl...
Prescription opioid utilization patterns, and associated outcomes, among privately insured patients prescribed opioids to manage pain associated with osteoarthritis [0.03%]
私人保险患者的利用模式及与治疗骨关节炎相关疼痛的处方阿片类药物相关的成果和关联结果
Patricia Schepman,J Bradford Rice,Craig G Beck et al.
Patricia Schepman et al.
Objective: To describe utilization patterns, negative clinical outcomes and economic burden of patients diagnosed with osteoarthritis (OA) of the hip and/or knee who received a prescription for tramadol or non-tramadol op...
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study [0.03%]
评估美国大型商业保险健康计划中免疫功能低下人群的新冠肺炎疫情风险和成本：EPOCH-US研究
Amita Ketkar,Vincent Willey,Michael Pollack et al.
Amita Ketkar et al.
Objective: To estimate the prevalence of patients with an immunocompromising condition at risk for COVID-19, estimate COVID-19 prevalence rate (PR) and incidence rate (IR) by immunocompromising condition, and describe COV...
Observed consensus on research priorities for the hypertriglyceridemia patient registry [0.03%]
高甘油三酯血症患者登记处的研究重点的共识观察结果
Steve Freedman,Enrique de-Madaria,Eric Bruckert et al.
Steve Freedman et al.
Background: Priority setting in health research has been described as essential due to disparities within and between countries and populations. Commercial benefits to the pharmaceutical industry may increase the generati...